Anne Samuel
Stock Analyst at JP Morgan
(3.47)
# 669
Out of 4,829 analysts
64
Total ratings
56.1%
Success rate
2.53%
Average return
Main Sectors:
Stocks Rated by Anne Samuel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMCL Omnicell | Maintains: Neutral | $44 → $36 | $25.78 | +39.64% | 5 | Mar 20, 2025 | |
| VEEV Veeva Systems | Maintains: Neutral | $218 → $249 | $237.05 | +5.04% | 6 | Mar 20, 2025 | |
| EVH Evolent Health | Maintains: Overweight | $13 → $12 | $9.05 | +32.60% | 12 | Mar 10, 2025 | |
| IQV IQVIA Holdings | Maintains: Overweight | $240 → $232 | $148.99 | +55.72% | 6 | Feb 18, 2025 | |
| PGNY Progyny | Maintains: Neutral | $17 → $23 | $21.19 | +8.54% | 7 | Jan 28, 2025 | |
| DOCS Doximity | Maintains: Neutral | $30 → $48 | $59.19 | -18.91% | 5 | Nov 21, 2024 | |
| PHR Phreesia | Maintains: Overweight | $27 → $28 | $25.62 | +9.29% | 2 | Sep 9, 2024 | |
| PINC Premier | Maintains: Neutral | $21 → $19 | $23.07 | -17.64% | 4 | Sep 9, 2024 | |
| CCSI Consensus Cloud Solutions | Downgrades: Underweight | $19 → $21 | $22.51 | -6.71% | 3 | Sep 9, 2024 | |
| HCAT Health Catalyst | Maintains: Overweight | $10 → $13 | $4.13 | +214.77% | 3 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $27 | $40.01 | -32.52% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $7 → $5 | $3.69 | +35.50% | 1 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $86 → $108 | $90.44 | +19.42% | 8 | Apr 2, 2024 |
Omnicell
Mar 20, 2025
Maintains: Neutral
Price Target: $44 → $36
Current: $25.78
Upside: +39.64%
Veeva Systems
Mar 20, 2025
Maintains: Neutral
Price Target: $218 → $249
Current: $237.05
Upside: +5.04%
Evolent Health
Mar 10, 2025
Maintains: Overweight
Price Target: $13 → $12
Current: $9.05
Upside: +32.60%
IQVIA Holdings
Feb 18, 2025
Maintains: Overweight
Price Target: $240 → $232
Current: $148.99
Upside: +55.72%
Progyny
Jan 28, 2025
Maintains: Neutral
Price Target: $17 → $23
Current: $21.19
Upside: +8.54%
Doximity
Nov 21, 2024
Maintains: Neutral
Price Target: $30 → $48
Current: $59.19
Upside: -18.91%
Phreesia
Sep 9, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $25.62
Upside: +9.29%
Premier
Sep 9, 2024
Maintains: Neutral
Price Target: $21 → $19
Current: $23.07
Upside: -17.64%
Consensus Cloud Solutions
Sep 9, 2024
Downgrades: Underweight
Price Target: $19 → $21
Current: $22.51
Upside: -6.71%
Health Catalyst
Sep 4, 2024
Maintains: Overweight
Price Target: $10 → $13
Current: $4.13
Upside: +214.77%
Aug 19, 2024
Maintains: Overweight
Price Target: $24 → $27
Current: $40.01
Upside: -32.52%
Jul 31, 2024
Downgrades: Underweight
Price Target: $7 → $5
Current: $3.69
Upside: +35.50%
Apr 2, 2024
Maintains: Overweight
Price Target: $86 → $108
Current: $90.44
Upside: +19.42%